Yang, F. (2025) „Combination of Prostate Cancer Antigen 3 (PCA3), Sarcosine, Glypican-1 (GPC1), Urokinase Plasminogen Activator Receptor (uPAR), and Thymidine Kinase 1 (TK1), and T2WI and DWI Radiomics Model for Distinguishing Benign Prostatic Hyperplasia, Prostate Cancer: -“, Journal of Medical Biochemistry, 44(6), str. 1376–1385. doi:10.5937/jomb0-57639.